Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,422,756,513
-$318,949,061 QoQ
Shares Held
59,084,573
-4.7% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#9
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. PFE ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
This page
|
59,084,573 | $1,422,756,513 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,422,756,513 | 59,084,573 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,741,705,574 | 62,026,552 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,574,939,660 | 63,250,589 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,631,224,677 | 64,019,807 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,530,771,315 | 63,150,632 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,579,339,744 | 62,325,957 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,548,889,312 | 58,382,560 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,568,991,878 | 54,215,338 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,585,336,557 | 56,659,634 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,602,141,364 | 57,734,824 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,721,809,267 | 59,805,810 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,093,434,790 | 63,112,294 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,313,597,747 | 63,075,184 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,700,148,078 | 66,180,100 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,419,318,318 | 66,731,427 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,913,881,031 | 66,587,775 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,511,674,783 | 66,978,348 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,443,268,255 | 66,510,880 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,014,938,522 | 67,992,185 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,917,755,861 | 67,839,011 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,516,045,347 | 64,250,392 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,356,872,035 | 65,053,051 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,455,918,105 | 66,718,775 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,518,657,554 | 68,628,339 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,247,604,512 | 68,734,012 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $2,285,320,873 | 70,016,053 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||